Shares of Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report) traded up 63% during mid-day trading on Thursday . The stock traded as high as $1.50 and last traded at $1.50. 39,500 shares traded hands during mid-day trading, an increase of 1,094% from the average session volume of 3,307 shares. The stock had previously closed at $0.92.
Idorsia Stock Up 63.0 %
The company has a fifty day moving average of $1.46 and a 200-day moving average of $2.11.
Idorsia Company Profile
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Read More
- Five stocks we like better than Idorsia
- Stock Market Upgrades: What Are They?
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- How to Use the MarketBeat Stock Screener
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- What Are Dividend Contenders? Investing in Dividend Contenders
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
